Home » Topics » Regulatory » Patents

Patents
RSS

Novel checkpoint kinase inhibitors claimed by DCB-USA

Aug. 19, 2009

Alios BioPharma describes RNAseL inhibitors in early development

Aug. 19, 2009

Vertex presents new JAK2 inhibitors for treatment of myeloproliferative disorders

Aug. 19, 2009

Bial Portela discloses FAAH inhibitors for the treatment of pain and other conditions

Aug. 19, 2009

Novel cytochrome P450 inhibitors in early development at Gilead

Aug. 19, 2009

Molecular InSight discloses carbonic anhydrase IX inhibitors for cancer therapy

Aug. 18, 2009

New protease inhibitors for hepatitis C virus therapy reported by Enanta

Aug. 18, 2009

PharmaMar discovers a new series of oncolytic compounds

Aug. 18, 2009

University of Sheffield divulges new compounds for treating motor neuron diseases

Aug. 18, 2009

Novel TRPA1 antagonists discovered at Abbott for the treatment of pain

Aug. 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...